Van Lanschot Kempen Investment Management N.V. Sells 3,890 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Van Lanschot Kempen Investment Management N.V. decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 47,606 shares of the healthcare conglomerate's stock after selling 3,890 shares during the quarter. Van Lanschot Kempen Investment Management N.V.'s holdings in UnitedHealth Group were worth $24,082,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Wealth Dimensions Group Ltd. boosted its stake in UnitedHealth Group by 13.2% in the 4th quarter. Wealth Dimensions Group Ltd. now owns 729 shares of the healthcare conglomerate's stock worth $369,000 after purchasing an additional 85 shares during the period. Tower Research Capital LLC TRC grew its stake in UnitedHealth Group by 6.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 54,849 shares of the healthcare conglomerate's stock valued at $27,746,000 after acquiring an additional 3,365 shares in the last quarter. Thematics Asset Management lifted its stake in UnitedHealth Group by 16.1% in the 4th quarter. Thematics Asset Management now owns 10,378 shares of the healthcare conglomerate's stock worth $5,250,000 after purchasing an additional 1,438 shares in the last quarter. Transce3nd LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $270,000. Finally, Trajan Wealth LLC raised its position in shares of UnitedHealth Group by 13.8% in the fourth quarter. Trajan Wealth LLC now owns 39,047 shares of the healthcare conglomerate's stock worth $19,752,000 after buying an additional 4,747 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research analyst reports. Barclays decreased their target price on UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating on the stock in a research note on Monday. Oppenheimer dropped their target price on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a research report on Monday. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Finally, JPMorgan Chase & Co. cut their target price on UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a research note on Thursday. Three equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $603.05.

UnitedHealth Group Trading Down 1.4 %

Shares of NYSE:UNH traded down $5.93 on Friday, hitting $418.32. The company had a trading volume of 6,294,780 shares, compared to its average volume of 4,463,734. UnitedHealth Group Incorporated has a 1 year low of $412.10 and a 1 year high of $630.73. The firm has a market capitalization of $382.64 billion, a price-to-earnings ratio of 26.98, a P/E/G ratio of 1.37 and a beta of 0.61. The firm's 50-day simple moving average is $504.95 and its two-hundred day simple moving average is $536.14. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the business posted $6.91 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.01%. UnitedHealth Group's payout ratio is currently 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.